ArticleJCO precision oncology2026

Tocilizumab for the Management of Osimertinib-Induced Pneumonitis in a Critically Ill Patient.

Caroline Hénin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.